357 related articles for article (PubMed ID: 20385908)
1. Reduced lean mass in early Alzheimer disease and its association with brain atrophy.
Burns JM; Johnson DK; Watts A; Swerdlow RH; Brooks WM
Arch Neurol; 2010 Apr; 67(4):428-33. PubMed ID: 20385908
[TBL] [Abstract][Full Text] [Related]
2. Bone density and brain atrophy in early Alzheimer's disease.
Loskutova N; Honea RA; Vidoni ED; Brooks WM; Burns JM
J Alzheimers Dis; 2009; 18(4):777-85. PubMed ID: 19661621
[TBL] [Abstract][Full Text] [Related]
3. Peripheral insulin and brain structure in early Alzheimer disease.
Burns JM; Donnelly JE; Anderson HS; Mayo MS; Spencer-Gardner L; Thomas G; Cronk BB; Haddad Z; Klima D; Hansen D; Brooks WM
Neurology; 2007 Sep; 69(11):1094-104. PubMed ID: 17846409
[TBL] [Abstract][Full Text] [Related]
4. Brain CT can predict low lean mass in the elderly with cognitive impairment: a community-dwelling study.
Chen YT; Yu CC; Lin YC; Chan SH; Lin YY; Chen NC; Lin WC
BMC Geriatr; 2022 Jan; 22(1):3. PubMed ID: 34979925
[TBL] [Abstract][Full Text] [Related]
5. White matter lesions are prevalent but differentially related with cognition in aging and early Alzheimer disease.
Burns JM; Church JA; Johnson DK; Xiong C; Marcus D; Fotenos AF; Snyder AZ; Morris JC; Buckner RL
Arch Neurol; 2005 Dec; 62(12):1870-6. PubMed ID: 16344345
[TBL] [Abstract][Full Text] [Related]
6. Role of lean body mass in estimating glomerular filtration rate in Alzheimer disease.
Wetmore JB; Honea RA; Vidoni ED; Almehmi A; Burns JM
Nephrol Dial Transplant; 2011 Jul; 26(7):2222-31. PubMed ID: 21098656
[TBL] [Abstract][Full Text] [Related]
7. Volumetric MRI and cognitive measures in Alzheimer disease : comparison of markers of progression.
Ridha BH; Anderson VM; Barnes J; Boyes RG; Price SL; Rossor MN; Whitwell JL; Jenkins L; Black RS; Grundman M; Fox NC
J Neurol; 2008 Apr; 255(4):567-74. PubMed ID: 18274807
[TBL] [Abstract][Full Text] [Related]
8. Determination of appendicular muscle mass by dual energy X-ray absorptiometry method in women with sarcopenia and Alzheimer's disease.
Gillette-Guyonnet S; Nourhashemi F; Andrieu S; de Glisezinski I; Grandjean H; Rolland Y; Riviere D; Vellas B
J Nutr Health Aging; 2000; 4(3):165-9. PubMed ID: 10936904
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and Prognostic Utility of the Synaptic Marker Neurogranin in Alzheimer Disease.
Tarawneh R; D'Angelo G; Crimmins D; Herries E; Griest T; Fagan AM; Zipfel GJ; Ladenson JH; Morris JC; Holtzman DM
JAMA Neurol; 2016 May; 73(5):561-71. PubMed ID: 27018940
[TBL] [Abstract][Full Text] [Related]
10. Cardiorespiratory fitness and brain atrophy in early Alzheimer disease.
Burns JM; Cronk BB; Anderson HS; Donnelly JE; Thomas GP; Harsha A; Brooks WM; Swerdlow RH
Neurology; 2008 Jul; 71(3):210-6. PubMed ID: 18625967
[TBL] [Abstract][Full Text] [Related]
11. Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis.
Calabrese M; Agosta F; Rinaldi F; Mattisi I; Grossi P; Favaretto A; Atzori M; Bernardi V; Barachino L; Rinaldi L; Perini P; Gallo P; Filippi M
Arch Neurol; 2009 Sep; 66(9):1144-50. PubMed ID: 19752305
[TBL] [Abstract][Full Text] [Related]
12. Muscle Strength Is Independently Related to Brain Atrophy in Patients with Alzheimer's Disease.
Moon Y; Moon WJ; Kim JO; Kwon KJ; Han SH
Dement Geriatr Cogn Disord; 2019; 47(4-6):306-314. PubMed ID: 31311027
[TBL] [Abstract][Full Text] [Related]
13. Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions.
Bennett DA; Schneider JA; Bienias JL; Evans DA; Wilson RS
Neurology; 2005 Mar; 64(5):834-41. PubMed ID: 15753419
[TBL] [Abstract][Full Text] [Related]
14. Muscle profile and cognition in patients with Alzheimer's disease dementia.
Moon Y; Choi YJ; Kim JO; Han SH
Neurol Sci; 2018 Nov; 39(11):1861-1866. PubMed ID: 30084072
[TBL] [Abstract][Full Text] [Related]
15. Total body mass, fat mass, fat-free mass, and skeletal muscle in older people: cross-sectional differences in 60-year-old persons.
Kyle UG; Genton L; Hans D; Karsegard VL; Michel JP; Slosman DO; Pichard C
J Am Geriatr Soc; 2001 Dec; 49(12):1633-40. PubMed ID: 11843996
[TBL] [Abstract][Full Text] [Related]
16. Sarcopenic obesity assessed using dual energy X-ray absorptiometry (DXA) can predict cardiovascular disease in patients with type 2 diabetes: a retrospective observational study.
Fukuda T; Bouchi R; Takeuchi T; Tsujimoto K; Minami I; Yoshimoto T; Ogawa Y
Cardiovasc Diabetol; 2018 Apr; 17(1):55. PubMed ID: 29636045
[TBL] [Abstract][Full Text] [Related]
17. The clinical relevance of adiposity when assessing muscle health in men treated with androgen deprivation for prostate cancer.
Owen PJ; Daly RM; Dalla Via J; Mundell NL; Livingston PM; Rantalainen T; Fraser SF
J Cachexia Sarcopenia Muscle; 2019 Oct; 10(5):1036-1044. PubMed ID: 31067013
[TBL] [Abstract][Full Text] [Related]
18. Whole-brain atrophy rate and cognitive decline: longitudinal MR study of memory clinic patients.
Sluimer JD; van der Flier WM; Karas GB; Fox NC; Scheltens P; Barkhof F; Vrenken H
Radiology; 2008 Aug; 248(2):590-8. PubMed ID: 18574133
[TBL] [Abstract][Full Text] [Related]
19. Arm lean mass determined by dual-energy X-ray absorptiometry is superior to characterize skeletal muscle and predict sarcopenia-related mortality in cirrhosis.
Eriksen CS; Kimer N; Suetta C; Møller S
Am J Physiol Gastrointest Liver Physiol; 2021 May; 320(5):G729-G740. PubMed ID: 33729006
[TBL] [Abstract][Full Text] [Related]
20. Education, cognitive function, and severity of neuropathology in Alzheimer disease.
Koepsell TD; Kurland BF; Harel O; Johnson EA; Zhou XH; Kukull WA
Neurology; 2008 May; 70(19 Pt 2):1732-9. PubMed ID: 18160675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
